Overview

Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy

Status:
Unknown status

Trial end date:
2020-12-31

Target enrollment:

Participant gender:

Summary

Idiopathic membranous nephropathy (IMN) remains a common cause of the nephrotic syndrome in adults. There are few randomized clinical trials regarding the therapeutic effect of mycophenolate mofetil in patients with Idiopathic membranous nephropathy. This study aims to evaluate whether treatment with mycophenolate mofetil is non-inferior to cyclosporins in inducing long-term remission (complete or partial) of proteinuria in patients with idiopathic membranous nephropathy.

Phase:

Phase 4

Details

Lead Sponsor:

Guangdong General Hospital
Guangdong Provincial People's Hospital

Treatments:

Cyclosporine
Cyclosporins
Mycophenolate mofetil
Mycophenolic Acid